Circulating calprotectin levels four months after severe and non-severe COVID-19

Circulating calprotectin levels four months after severe and non-severe COVID-19

Abstract Background Calprotectin is an inflammatory marker mainly released by activated neutrophils that is increased in acute severe COVID-19. After initial recovery, some patients have persistent respiratory impairment with reduced diffusion capacity of the lungs for carbon monoxide (DLCO) months...

Full description

Bibliographic Details
Main Authors: N. Abu Hussein, C. Machahua, SC. Ruchti, MP. Horn, L. Piquilloud, M. Prella, TK. Geiser, C. von Garnier, M. Funke-Chambour
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Infectious Diseases
Subjects:
Long COVID
Calprotectin
Post COVID sequelae
ARDS sequelae
Post-infectious inflammation
Online Access:https://doi.org/10.1186/s12879-023-08653-7

Internet

https://doi.org/10.1186/s12879-023-08653-7

Similar Items